Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,000 shares, a growth of 566.7% from the March 31st total of 300 shares. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is presently 1.0 days. Approximately 0.0% of the company's shares are short sold.
Aspen Pharmacare Stock Down 4.4 %
Aspen Pharmacare stock traded down $0.29 during trading hours on Wednesday, hitting $6.30. The company had a trading volume of 234 shares, compared to its average volume of 1,357. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.81 and a quick ratio of 1.07. The company has a 50-day moving average price of $8.74 and a two-hundred day moving average price of $9.21. Aspen Pharmacare has a 1 year low of $5.76 and a 1 year high of $13.69.
Aspen Pharmacare Company Profile
(
Get Free Report)
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Featured Articles
Before you consider Aspen Pharmacare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.
While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.